Cargando…

Impact of Discontinuing Levofloxacin Prophylaxis on Bloodstream Infections in Neutropenic Hematopoietic Stem Cell Transplantation Patients

Multidrug-resistant pathogens have emerged worldwide. We have driven the hypothesis that the non-use of fluoroquinolone prophylaxis during neutropenia could reduce antibiotic resistance in Gram-negative bacteria that cause bloodstream infections (BSIs) in hematopoietic stem cell transplantation (HSC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guimarães, Thaís, Borges, Igor Carmo, Spadão, Fernanda de Souza, Mariano, Livia, Nascimento, Marina de Mattos, Higashino, Hermes, Rossi, Flavia, Rocha, Vanderson, Costa, Silvia Figueiredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495722/ https://www.ncbi.nlm.nih.gov/pubmed/36140048 http://dx.doi.org/10.3390/antibiotics11091269

Ejemplares similares

2685. Oral Third-Generation Cephalosporins vs. Levofloxacin for Antibacterial Prophylaxis in Neutropenic Patients with Hematologic Malignancies
por: DeVoe, Catherine, et al.
Publicado: (2019)

Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis
por: De Rosa, Francesco Giuseppe, et al.
Publicado: (2013)

Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2019)

194. Antibiotic-resistant bloodstream infections in pediatric oncology patients on levofloxacin prophylaxis
por: Sridhar, Sunita, et al.
Publicado: (2020)

1595. Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients with Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2018)

1364. Effect of Cefepime Prophylaxis on Bacterial Bloodstream Infections in Neutropenic Patients with Acute Myelogenous Leukemia
por: Dassner, Aimee, et al.
Publicado: (2020)

Capnocytophaga sputigena bloodstream infection in hematopoietic stem cell transplantations: two cases report and review of the literature
por: Mendes, Fernanda Rodrigues, et al.
Publicado: (2020)

Rhodococcus hoagii bloodstream infection in an allogeneic hematopoietic stem cell transplantation patient: Case report and review of literature
por: da Silva Campana, Pedro, et al.
Publicado: (2020)

Antibacterial prophylaxis in neutropenic children with cancer
por: Barone, Angelica
Publicado: (2011)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit
por: Lopes, Livia Amaral Alonso, et al.
Publicado: (2014)

Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients
por: Horasan, Elif Sahin, et al.
Publicado: (2011)

Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients
por: Lendak, Dajana, et al.
Publicado: (2021)

Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy
por: Linden-Castro, Edgar, et al.
Publicado: (2014)

Bacterial Landscape of Bloodstream Infections in Neutropenic Patients via High Throughput Sequencing
por: Gyarmati, Peter, et al.
Publicado: (2015)

Prophylaxis with levofloxacin: bacterial infections and antimicrobial resistance in hematological malignancies
por: Campos, Claudio Penido
Publicado: (2014)

Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients: a pilot study in China
por: He, Lixian, et al.
Publicado: (2015)

Bloodstream Infections caused by Klebsiella pneumoniae and Serratia marcescens isolates co-harboring NDM-1 and KPC-2
por: Bes, Taniela, et al.
Publicado: (2021)

Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
por: Clerici, Daniela, et al.
Publicado: (2022)

Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia: A Two-Center Retrospective Study
por: Van Weelderen, Romy E., et al.
Publicado: (2022)

Catheter-Related Trichosporon asahii Bloodstream Infection in a Neutropenic Patient with Myelodysplastic Syndrome
por: Go, Se-Eun, et al.
Publicado: (2018)

Frequency of bloodstream infection in febrile neutropenic patients, experience from a developing country
por: Siddiqui, Basit, et al.
Publicado: (2018)

INCIDENCE OF DIARRHEA BY Clostridium difficile IN HEMATOLOGIC PATIENTS AND HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS: RISK FACTORS FOR SEVERE FORMS AND DEATH
por: Spadão, Fernanda, et al.
Publicado: (2014)

Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study
por: Urbino, Irene, et al.
Publicado: (2023)

Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study
por: Cho, Sung-Yeon, et al.
Publicado: (2013)

High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases
por: Liu, Li-Peng, et al.
Publicado: (2023)

Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome
por: Niessen, F. A., et al.
Publicado: (2020)

1664. The Impact of Levofloxacin Prophylaxis on Empiric Intravenous Antibiotic Use in Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Prodanuk, Michael, et al.
Publicado: (2023)

1087. Fluoroquinolone Prophylaxis vs. No Bacterial Prophylaxis in Hospitalized Neutropenic Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia
por: Buchanan, Carley, et al.
Publicado: (2019)

Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model
por: Forgács, Lajos, et al.
Publicado: (2020)

Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance
por: Garnica, Marcia, et al.
Publicado: (2013)

Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
por: Randi, Bruno Azevedo, et al.
Publicado: (2023)

Neutropenic diets in hematopoietic stem cell transplantation
por: Albertini, Silvia Maria
Publicado: (2012)

Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital
por: Kimura, Muneyoshi, et al.
Publicado: (2016)

Neutropenic Fever
por: Baluch, Aliyah, et al.
Publicado: (2019)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

1591. Infectious Outcomes of Levofloxacin Prophylaxis in Obese vs. Non-obese Patients with Hematologic Malignancies
por: Kurtti, Amanda, et al.
Publicado: (2018)

478. Outcomes of Extended-Spectrum β-Lactamase-Producing Escherichia coli Bloodstream Infection in Neutropenic Patients with Hematological Malignancies
por: Aslam, Sadaf, et al.
Publicado: (2019)

2249. Impact of Minimum Inhibitory Concentration on Clinical Outcomes of Daptomycin for VRE Bloodstream Infection Among Neutropenic Oncology Patients
por: Caulder, Elisabeth, et al.
Publicado: (2019)

Characteristics, Outcomes, and Clinical Indicators of Bloodstream Infections in Neutropenic Patients with Hematological Malignancies: A 7-Year Retrospective Study
por: Wang, Shuyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_09hdalg1f5l9g16ntevi6gm4n1